SEC Form 4 · accession 0001645627-17-000027
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 3, 2017
Accepted (ET)
Apr 5, 2017 · 3:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 3, 2017 | P | 2,000 | $0.076 | A | 20,014,349 | D | |
| Common Stock | Apr 3, 2017 | P | 2,000 | $0.076 | A | 20,016,349 | D | |
| Common Stock | Apr 3, 2017 | P | 2,000 | $0.075 | A | 20,018,349 | D | |
| Common Stock | Apr 3, 2017 | P | 1,000 | $0.074 | A | 20,019,349 | D | |
| Common Stock | Apr 3, 2017 | P | 1,000 | $0.0775 | A | 20,020,349 | D | |
| Common Stock | Apr 3, 2017 | P | 1,000 | $0.078 | A | 20,021,349 | D | |
| Common Stock | Apr 3, 2017 | P | 1,000 | $0.08 | A | 20,022,349 | D | |
| Common Stock | Apr 3, 2017 | P | 2,000 | $0.078 | A | 20,024,349 | D | |
| Common Stock | Apr 3, 2017 | P | 500 | $0.08 | A | 20,024,849 | D | |
| Common Stock | Apr 3, 2017 | P | 1,000 | $0.087 | A | 20,025,849 | D | |
| Common Stock | Apr 3, 2017 | P | 1,000 | $0.087 | A | 20,026,849 | D | |
| Common Stock | Apr 3, 2017 | P | 1,000 | $0.086 | A | 20,027,849 | D | |
| Common Stock | Apr 3, 2017 | P | 1,000 | $0.085 | A | 20,028,849 | D | |
| Common Stock | Apr 4, 2017 | P | 1,000 | $0.0105 | A | 20,029,849 | D | |
| Common Stock | Apr 4, 2017 | P | 1,000 | $0.0999 | A | 20,030,849 | D | |
| Common Stock | Apr 4, 2017 | P | 1,000 | $0.0105 | A | 20,031,849 | D |
Table II — derivative securities
No Table II lines on this filing.